Neuberger Berman Group LLC Cytokinetics Inc Transaction History
Neuberger Berman Group LLC
- $118 Billion
- Q1 2024
A detailed history of Neuberger Berman Group LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Neuberger Berman Group LLC holds 78,002 shares of CYTK stock, worth $4.48 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
78,002Holding current value
$4.48 Million% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding CYTK
# of Institutions
461Shares Held
107MCall Options Held
7.2MPut Options Held
6.2M-
Black Rock Inc. New York, NY12.4MShares$713 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$574 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.12MShares$294 Million0.22% of portfolio
-
Bank Of America Corp Charlotte, NC4.78MShares$274 Million0.03% of portfolio
-
State Street Corp Boston, MA4.52MShares$260 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.41B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...